Latest News & Features
Generics
Patent protection is a global affair, so if you find yourself embroiled in litigation, it helps to know what benefits and challenges different jurisdictions can offer. 11 May 2021
Big Pharma
MSD, known as Merck in the US and Canada, has prevailed against a bid by Mylan Pharmaceuticals and other generic drug makers to invalidate a diabetes treatment patent. 11 May 2021
article
Brazil’s Supreme Court has ruled that the country’s ten-year patent term is unconstitutional. 11 May 2021
Genetics
The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences. 6 May 2021
Big Pharma
Sanofi-Aventis has been awarded $17.2 million in attorney fees, legal expenses and interest in a district court ruling on a failed suit levied by Amphastar Pharmaceuticals. 6 May 2021
article
Patent litigation is increasingly a multi-jurisdiction, cross-border affair that requires strategic consideration. When protecting patents on a global sphere you have to understand the balance between risks and benefits for each jurisdiction. Patent laws vary from country to country, and so must your strategy. 6 May 2021
Medtech
US medtech company Conformis has filed a lawsuit against J&J Medical Devices-owned DePuy Synthes, alleging that it infringed on its custom implant and surgery software patents. 4 May 2021
Americas
Pharmaceutical company Novartis has abandoned its attempt to halt US imports of Regeneron’s Eylea pre-filled syringes amid concerns that such a ban could hinder public access to essential treatments. 4 May 2021
Medtech
The US Court of Appeals for the Federal Circuit has affirmed a US International Trade Commission (ITC) decision that ruled Bio-Rad Laboratories had infringed three 10x Genomics patents. 4 May 2021
Americas
GlaxoSmithKline has submitted an amicus brief to the Court of Appeals for the Federal Circuit claiming that the ruling on Amgen v Sanofi could “threaten incentives to invest in future discoveries.” 29 April 2021